Inositol and IP3 levels regulate autophagy: Biology and therapeutic speculations

Autophagy

Volumn 2, Issue 2, 2006, Pages 132-134

  Sarkar, Sovan ^a   Rubinsztein, David C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Autophagy; Bipolar affective disorders; Huntington's disease; Inositol monophosphatase; Lithium

Indexed keywords

INOSITOL; INOSITOL PHOSPHATE; MAMMALIAN TARGET OF RAPAMYCIN; MYO INOSITOL 1,4,5 TRIPHOSPHATE; PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; AUTOSOMAL DOMINANT INHERITANCE; DEGENERATIVE DISEASE; DRUG STABILITY; ENZYME INHIBITION; HUNTINGTON CHOREA; PARKINSON DISEASE;

MAMMALIA;

EID: 33645916698     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.2387     Document Type: Article

References (18)

1. Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: A unifying hypothesis. Cell 1989; 59:411-9.
2. Rowe MK, Chuang DM. Lithium neuroprotection: Molecular mechanisms and clinical implications. Expert Rev Mol Med 2004; 6:1-18.
3. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004; 10:S10-7.
4. Rubinsztein DC. Lessons from animal models of Huntington's disease. Trends Genet 2002; 18:202-9.
5. Carmichael J, Sugars KL, Bao YP, Rubinsztein DC. Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation. J Biol Chem 2002; 277:33791-8.
6. Berger Z, Ttofi EK, Michel CH, Pasco MY, Tenant S, Rubinsztein DC, O'Kane CJ. Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway. Hum Mol Genet 2005; 14:3003-11.
7. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005; 170:1101-11.
8. Ravikumar B, Duden R, Rubinsztein DC. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 2002; 11:1107-17.
9. Atack JR, Cook SM, Watt AP, Fletcher SR, Ragan CI. In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330. J Neurochem 1993; 60:652-8.
10. Maeda T, Eisenberg Jr F. Purification, structure, and catalytic properties of L-myo-inositol-1-phosphate synthase from rat testis. J Biol Chem 1980; 255:8458-64.
11. Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002; 417:292-5.
12. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717-21.
13. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004; 36:585-95.
14. Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC. α-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 2003; 278:25009-13.
15. Moore GJ, Bebchuk JM, Parrish JK, Faulk MW, Arfken CL, Strahl-Bevacqua J, Manji HK. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 1999; 156:1902-8.
16. Gould TD, Chen G, Manji HK. Mood stabilizer psychopharmacology. Clin Neurosci Res 2002; 2:193-212.
17. Ogawa M, Yoshimori T, Suzuki T, Sagara H, Mizushima N, Sasakawa C. Escape of intracellular Shigella from autophagy. Science 2005; 307:727-31.
18. Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kamimoto T, Nara A, Funao J, Nakata M, Tsuda K, Hamada S, Yoshimori T. Autophagy defends cells against invading group A Streptococcus. Science 2004; 306:1037-40.